Chemoinformaics analysis of (-)-Dihydrojasmonic acid
Molecular Weight | 212.289 | nRot | 6 |
Heavy Atom Molecular Weight | 192.129 | nRig | 7 |
Exact Molecular Weight | 212.141 | nRing | 1 |
Solubility: LogS | -2.347 | nHRing | 0 |
Solubility: LogP | 2.328 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 35.7819 |
nHD | 1 | BPOL | 21.8001 |
QED | 0.688 |
Synth | 3.083 |
Natural Product Likeliness | 1.7 |
NR-PPAR-gamma | 0.592 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.049 |
Pgp-sub | 0.001 |
HIA | 0.017 |
CACO-2 | -4.73 |
MDCK | 0.0000185 |
BBB | 0.102 |
PPB | 0.898372 |
VDSS | 0.296 |
FU | 0.0805338 |
CYP1A2-inh | 0.03 |
CYP1A2-sub | 0.749 |
CYP2c19-inh | 0.016 |
CYP2c19-sub | 0.541 |
CYP2c9-inh | 0.023 |
CYP2c9-sub | 0.967 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.353 |
CYP3a4-inh | 0.008 |
CYP3a4-sub | 0.08 |
CL | 10.25 |
T12 | 0.849 |
hERG | 0.006 |
Ames | 0.02 |
ROA | 0.063 |
SkinSen | 0.076 |
Carcinogencity | 0.283 |
EI | 0.814 |
Respiratory | 0.064 |
NR-Aromatase | 0.007 |
Antiviral | Yes |
Prediction | 0.60222 |